{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:11:44Z","timestamp":1791130304699,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1067\/mjd.2000.100967","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:22:26Z","timestamp":1027556546000},"page":"118-122","source":"Crossref","is-referenced-by-count":36,"special_numbering":"P1","title":["Pilomatrix dysplasia in an immunosuppressed patient"],"prefix":"10.1067","volume":"43","author":[{"given":"Mark A.","family":"Chastain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry E.","family":"Millikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.100967_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-101-5-667","article-title":"Cyclosporine: a new immunosuppressive agent for organ transplantation","volume":"101","author":"Cohen","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2000.100967_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000249288","article-title":"Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients","volume":"172","author":"Bencini","year":"1986","journal-title":"Dermatologica"},{"key":"10.1067\/mjd.2000.100967_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2133.1984.tb04662.x","article-title":"Dermatological aspects of the use of cyclosporin A for prophylaxis of graft-versus-host disease","volume":"110","author":"Harper","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/archderm.1996.03890300039008","article-title":"Long-term safety of cyclosporine in the treatment of psoriasis","volume":"132","author":"Grossman","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0190-9622(98)70325-1","article-title":"Cyclosporine consensus conference: with emphasis on the treatment of psoriasis","volume":"39","author":"Lebwohl","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archderm.1990.01670270101017","article-title":"Cyclosporine: an immunosuppressant affecting epithelial cell proliferation","volume":"126","author":"Kanitakis","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/1523-1747.ep12277577","article-title":"Cutaneous papillomatous hyperplasia in cyclosporine-A treated beagles","volume":"93","author":"Seibel","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib8","first-page":"365","article-title":"The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration","volume":"60","author":"Paus","year":"1989","journal-title":"Lab Invest"},{"key":"10.1067\/mjd.2000.100967_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1523-1747.ep12468979","article-title":"Cyclosporin A prolongs human hair growth in vitro","volume":"100","author":"Taylor","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2230.1987.tb01893.x","article-title":"Hypertrichosis in patients receiving cyclosporine therapy","volume":"12","author":"Wysocki","year":"1987","journal-title":"Clin Exp Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib11","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(87)90595-2","article-title":"Changes in facial appearance during cyclosporin treatment","volume":"1","author":"Reznik","year":"1987","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.100967_bib12","first-page":"177","article-title":"Cyclosporin-A for the prevention of graft versus host disease following allogenic bone marrow transplantation in man","volume":"41","author":"Morgenstern","year":"1980","journal-title":"Blut"},{"key":"10.1067\/mjd.2000.100967_bib13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0140-6736(87)91439-5","article-title":"Cyclosporin-induced dysmorphic changes in the BB\/W rat [letter]","volume":"2","author":"Mu","year":"1987","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.100967_bib14","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archderm.1993.01680270138031","article-title":"Papilloma development in cyclosporine-treated patients","volume":"129","author":"Valicenti","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib15","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0041-1345(98)00229-2","article-title":"Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis","volume":"30","author":"Busque","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1067\/mjd.2000.100967_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2133.1994.tb08482.x","article-title":"Excess granulation tissue development during treatment with cyclosporin","volume":"131","author":"Wakelin","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1365-2133.1995.tb00737.x","article-title":"Cyclosporin-induced periungual granulation tissue","volume":"132","author":"Higgins","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2133.1997.tb08764.x","article-title":"Hyperplastic pseudofolliculitis barbae associated with cyclosporin","volume":"136","author":"Lear","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0190-9622(08)80529-4","article-title":"Multiple eruptive benign keratoses associated with cyclosporine therapy for psoriasis","volume":"26","author":"Ross","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.100967_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-051X.1992.tb01141.x","article-title":"Nifedipine-induced gingival overgrowth","volume":"19","author":"Hancock","year":"1992","journal-title":"J Clin Periodontol"},{"key":"10.1067\/mjd.2000.100967_bib21","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0733-8635(18)30052-4","article-title":"Cyclosporine: what clinicians need to know","volume":"13","author":"Koo","year":"1995","journal-title":"Dermatol Clin"},{"key":"10.1067\/mjd.2000.100967_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/archinte.1989.00390040057011","article-title":"Cutaneous adverse reactions associated with calcium channel blockers","volume":"149","author":"Stern","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1067\/mjd.2000.100967_bib23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/1523-1747.ep12606018","article-title":"Induction of anagen in telogen mouse skin by topical application of FK506, a potent immunosuppressant","volume":"104","author":"Jiang","year":"1995","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200224109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200224109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,15]],"date-time":"2019-12-15T22:33:55Z","timestamp":1576449235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200224109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S0190962200224109"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.100967","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}